Home/Filings/4/0001213900-21-058202
4//SEC Filing

Erfanian Hamid 4

Accession 0001213900-21-058202

CIK 0000316253other

Filed

Nov 9, 7:00 PM ET

Accepted

Nov 10, 5:20 PM ET

Size

7.2 KB

Accession

0001213900-21-058202

Insider Transaction Report

Form 4
Period: 2021-11-08
Erfanian Hamid
Chief Executive Officer
Transactions
  • Award

    Stock Option (to acquire Common Stock)

    2021-11-08+700,000700,000 total
    Exercise: $3.39From: 2022-11-08Exp: 2026-11-08Common Stock (700,000 underlying)
  • Award

    Common Stock, $0.01 Par Value

    2021-11-08+260,000260,000 total
Footnotes (2)
  • [F1]The Reporting Person was granted Restricted Stock Units that will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.
  • [F2]The Reporting Person was granted 700,000 stock options. The stock options have a five-year term and will vest, subject to the individual's continued employment with Enzo Biochem, Inc., in three equal annual installments, beginning on November 8, 2022.

Documents

1 file

Issuer

ENZO BIOCHEM INC

CIK 0000316253

Entity typeother

Related Parties

1
  • filerCIK 0001893172

Filing Metadata

Form type
4
Filed
Nov 9, 7:00 PM ET
Accepted
Nov 10, 5:20 PM ET
Size
7.2 KB